Pallas Capital Advisors’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $556K | Buy |
6,372
+300
| +5% | +$26.2K | 0.02% | 473 |
|
|
2025
Q1 | $415K | Buy |
6,072
+2,571
| +73% | +$176K | 0.02% | 522 |
|
|
2024
Q4 | $272K | Buy |
+3,501
| New | +$272K | 0.01% | 488 |
|
|
2024
Q3 | – | Sell |
-5,179
| Closed | -$573K | – | 611 |
|
|
2024
Q2 | $573K | Buy |
5,179
+45
| +0.9% | +$4.98K | 0.03% | 292 |
|
|
2024
Q1 | $712K | Buy |
5,134
+83
| +2% | +$11.5K | 0.03% | 237 |
|
|
2023
Q4 | $627K | Sell |
5,051
-25
| -0.5% | -$3.1K | 0.03% | 242 |
|
|
2023
Q3 | $431K | Buy |
5,076
+15
| +0.3% | +$1.27K | 0.03% | 249 |
|
|
2023
Q2 | $696K | Buy |
5,061
+819
| +19% | +$113K | 0.03% | 175 |
|
|
2023
Q1 | $525K | Buy |
4,242
+166
| +4% | +$20.6K | 0.05% | 180 |
|
|
2022
Q4 | $440K | Buy |
4,076
+12
| +0.3% | +$1.29K | 0.04% | 193 |
|
|
2022
Q3 | $458K | Sell |
4,064
-3
| -0.1% | -$338 | 0.05% | 172 |
|
|
2022
Q2 | $341K | Sell |
4,067
-853
| -17% | -$71.5K | 0.05% | 173 |
|
|
2022
Q1 | $605K | Sell |
4,920
-1,232
| -20% | -$151K | 0.08% | 144 |
|
|
2021
Q4 | $649K | Sell |
6,152
-212
| -3% | -$22.4K | 0.08% | 163 |
|
|
2021
Q3 | $986K | Buy |
6,364
+116
| +2% | +$18K | 0.11% | 148 |
|
|
2021
Q2 | $804K | Buy |
6,248
+1,788
| +40% | +$230K | 0.11% | 139 |
|
|
2021
Q1 | $382K | Buy |
+4,460
| New | +$382K | 0.09% | 140 |
|